|
|
Volumn 39, Issue 4, 1996, Pages 422-423
|
|
Exercise, drug treatment, and the optimal care of multiple sclerosis patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLATIRAMER;
INTERFERON BETA SERINE;
LIPID;
AEROBIC CAPACITY;
BODY COMPOSITION;
CLINICAL TRIAL;
DISABILITY;
EDITORIAL;
EXERCISE;
HUMAN;
MULTIPLE SCLEROSIS;
MUSCLE STRENGTH;
OCCUPATIONAL THERAPY;
PATIENT CARE;
PHASE 3 CLINICAL TRIAL;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
EXERCISE THERAPY;
HUMANS;
MULTIPLE SCLEROSIS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0029917743
PISSN: 03645134
EISSN: None
Source Type: Journal
DOI: 10.1002/ana.410390403 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|
